title: Response to the letter "Actigraphic evaluation for patients with attention deficit/hyperactivity disorder".
authors.forename: Aurelie
authors.initials: A
authors.lastname: Labbe
authors.forename: Ridha
authors.initials: R
authors.lastname: Joober
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology*; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*; D010641:Phenotype; D043562:Receptors, G-Protein-Coupled / Q000235:genetics*; D018000:Receptors, Peptide / Q000235:genetics*
chemical_list: D018765:Dopamine Uptake Inhibitors; D043562:Receptors, G-Protein-Coupled; D018000:Receptors, Peptide; D008774:Methylphenidate